Trial Condition(s):

Erectile Dysfunction

Real life safety and efficacy of vardenafil

Bayer Identifier:

14328

ClinicalTrials.gov Identifier:

NCT01215409

EudraCT Number:

Not Available

Terminated/Withdrawn

Trial Purpose

In this uncontrolled, non-randomized, prospective, local post-marketed surveillance study, data are obtained on safety and efficacy of LEVITRA® in routine treatment of erectile dysfunction. The general objectives are to evaluate the product safety (primarily by recording adverse events), efficacy and patient acceptance.

Inclusion Criteria
- Any adult patient (>/=18 years) with erectile dysfunction treated with LEVITRA®.
 - Patients must be able to give written informed consent for participation in the study after receiving detailed written and oral information prior to the study.
Exclusion Criteria
- Exclusion criteria must be read in conjunction with the product information (Package Insert).

Trial Summary

Enrollment Goal
372
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Levitra (Vardenafil, BAY38-9456)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, Taiwan, China

Status
Terminated
 

Trial Design